Introduction
Methods
Participants and Measurements
Polysomnography and Definitions
Statistical Analysis
Results
Characteristic | Number (%) | Mean ± SD | Range |
---|---|---|---|
Total number of patient | 44 | ||
Male | 18 (40.9) | ||
Female | 26 (59.1) | ||
Cured group | 28 (63.6) | ||
Improved group | 35 (79.5) | ||
Height (m) | 1.67 ± 0.08 | 1.53–1.84 | |
Preoperative weight (kg) | 83.3 ± 12.7 | 67.0–131.0 | |
Age (years) | 48 ± 11 | 24–66 | |
Length of follow-up (months) | 9.7 ± 5.5 | 6.0–24.7 |
Anthropometric Characteristic Data and Blood Parameters
Characteristic | Preoperative (SD) | Postoperative (SD) | Mean difference (95 % CI) |
p Valuea
|
---|---|---|---|---|
Weight (kg) | 86.3 (12.7) | 67.9 (10.7) | −18.4 (−20.4 to −16.4) | <0.001 |
BMI (kg/m2) | 31.1 (3.4) | 24.4 (2.6) | −6.7 (−7.4 to −5.9) | <0.001 |
NC (cm) | 39.6 (2.9) | 35.1 (3.4) | −4.5 (−5.3 to −3.7) | <0.001 |
WC (cm) | 105.0 (9.6) | 87.7 (9.0) | −17.4 (−19.8 to −15.0) | <0.001 |
HC (cm) | 108.1 (8.6) | 95.4 (6.8) | −12.6 (−14.5 to −10.8) | <0.001 |
W/H ratio | 0.97 (0.05) | 0.92 (0.07) | −0.05 (−0.07 to −0.03) | <0.001 |
AHI (/h) | 22.4 (17.8) | 7.1 (9.4) | −15.4 (−20.3 to −10.4) | <0.001 |
Apnea index (/h) | 10.1 (13.4) | 4.4 (8.0) | −5.7 (−9.7 to −1.8) | 0.001 |
Hypopnea index (/h) | 12.3 (9.7) | 2.7 (3.2) | −9.7 (−12.6 to −6.7) | <0.001 |
Mean SaO2 (%) | 93.4 (2.9) | 95.5 (1.7) | 4.3 (−1.7 to 10.4) | <0.001 |
Minimum SaO2 (%) | 77.1 (11.9) | 86.7 (6.7) | 10.8 (5.7 to 15.8) | <0.001 |
CT90% (%) | 8.0 (12.7) | 1.4 (3.2) | −6.7 (−10.4 to −2.9) | <0.001 |
ODI (events/h) | 25.4 (18.6) | 6.4 (9.0) | −17.8 (−22.9 to −12.7) | <0.001 |
Arousal index (/h) | 19.8 (13.5) | 18.0 (13.4) | −1.4 (−6.0 to 3.2) | 0.163 |
ESS | 6.8 (4.7) | 3.0 (2.7) | −3.8 (−5.1 to −2.6) | <0.001 |
Glucose (mmol/L) | 8.2 (2.5) | 5.7 (1.2) | −2.5 (−3.2 to −1.9) | <0.001 |
Insulin (uU/mL) | 20.6 (17.2) | 7.3 (4.9) | −13.3 (−17.8 to −8.8) | <0.001 |
IR index | 1.75 (0.71) | 0.46 (0.59) | −1.30 (−1.47 to −1.13) | <0.001 |
Effect of LYGB on OSA
Groupa
| Number | Change of AHI (95 % CI) | Number of cured | Number of improved |
---|---|---|---|---|
Female | 26 | −13.1 (−18.7 to −7.4) | 16 (61.5 %) | 20 (76.9 %) |
Male | 18 | −18.7 (−28.0 to 9.4) | 12 (66.7 %) | 15 (83.3 %) |
Age <40 years | 9 | −13.3 (−22.3 to −4.4) | 8 (88.9 %) | 8 (88.9 %) |
Age ≥40 years | 35 | −15.9 (−21.8 to −10.0) | 20 (57.1 %) | 27 (77.1 %) |
PRE-BMI <30.0 kg/m2
| 22 | −12.5 (−19.2 to −5.9) | 15 (68.2 %) | 17 (77.3 %) |
PRE-BMI ≥30.0 kg/m2
| 22 | −18.2 (−25.8 to −10.6) | 13 (59.1 %) | 18 (81.8 %) |
Mild OSA at baseline | 22 | −5.15 (−7.0 to −3.3)b
| 17 (77.3 %) | 17 (77.3 %) |
Moderate OSA at baseline | 9 | −15.5 (−20.1 to −10.8) | 5 (55.6 %) | 7 (77.8 %) |
Severe OSA at baseline | 13 | −32.6 (−44.2 to −21.0) | 6 (46.2 %) | 11 (84.6 %) |
PRE-IR index <1 | 6 | −14.1 (−28.1 to −0.1) | 4 (66.7 %) | 5 (83.3 %) |
PRE-IR index ≥1 | 38 | −15.6 (−21.1 to −10.1) | 24 (63.2 %) | 30 (78.9 %) |
Follow-up <1 year | 31 | −16.4 (−23.2 to −9.7) | 20 (64.5 %) | 25 (80.6 %) |
Follow-up ≥1 year | 13 | −12.8 (−18.4 to −7.2) | 8 (61.5 %) | 10 (76.9 %) |
Parameters | Cured group (n = 28) | Uncured group (n = 16) |
p valueb
|
p valuec
| ||||
---|---|---|---|---|---|---|---|---|
PRE (SD) | POST (SD) | Mean difference (95 % CI) | PRE (SD) | POST (SD) | Mean difference (95 % CI) | |||
Total AHI | 17.6 (14.9) | 2.0 (1.4)a
| −15.6 (−21.4 to −9.9) | 30.8 (19.8) | 15.9 (11.0)a
| −14.9 (−25.0 to −4.9) | 0.012 | 0.494 |
Age | 45.6 (11.8) | 46.4 (11.9) | 0.8 (0.6 to 1.0) | 52.1 (8.6) | 52.8 (8.6) | 0.8 (0.6 to 1.0) | 0.063 | 0.922 |
Weight | 86.1 (14.1) | 67.4 (11.4)a
| 18.8 (−21.6 to −16.0) | 86.6 (10.1) | 68.9 (9.6)a
| −17.7 (−20.6 to −14.9) | 0.912 | 0.608 |
BMI | 30.9 (3.5) | 24.1 (2.5)a
| −6.8 (−7.8 to −5.8) | 31.4 (3.4) | 24.9 (2.8)a
| −6.5 (−7.5 to −5.4) | 0.656 | 0.671 |
NC | 39.1 (2.8) | 35.0 (3.3)a
| −4.1 (−5.2 to −3.1) | 40.5 (2.9) | 35.4 (3.7)a
| −5.1 (−6.4 to −3.8) | 0.187 | 0.239 |
WC | 103.4 (9.4) | 86.6 (9.1)a
| −16.9 (−20.1 to −13.6) | 107.9 (9.7) | 89.6 (8.9)a
| −18.3 (−22.2 to −14.3) | 0.150 | 0.572 |
HC | 107.0 (8.2) | 95.0 (6.1)a
| −12.0 (−14.4 to −9.5) | 109.9 (9.3) | 96.1 (8.1)a
| −13.8 (−17.0 to −10.7) | 0.297 | 0.350 |
Glucose | 7.9 (2.3) | 5.6 (1.2)a
| −2.3 (−3.1 to −1.5) | 8.9 (2.6) | 6.0 (1.1)a
| −2.9 (−4.2 to −1.6) | 0.242 | 0.388 |
Insulin | 19.7 (14.6) | 7.2 (5.0)a
| −12.4 (−17.4 to −7.5) | 22.3 (21.4) | 7.5 (4.8)a
| −14.8 (−24.4 to −5.2) | 0.981 | 0.884 |
IR | 1.7 (0.7) | 0.4 (0.6)a
| −1.3 (−1.5 to −1.1) | 1.8 (0.8) | 0.5 (0.6)a
| −1.3 (−1.7 to −1.0) | 0.522 | 0.799 |